Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2015 (2015), Article ID 791063, 8 pages
http://dx.doi.org/10.1155/2015/791063
Research Article

The Efficient Apoptotic Induction of Paclitaxel-Loaded Poly(N-vinylpyrrolidone)-block-poly(ε-caprolactone) Nanoparticles in the In Vitro Study of Lung Cancer Cell Lines

1Department of Nephrology, Xuzhou Medical College Affiliated Huai’an Hospital and Huai’an Second Hospital, Huai’an 223002, China
2Department of Otolaryngology Head and Neck Surgery, Guiyang Medical College Affiliated Hospital and The Affiliated Baiyun Hospital of Guiyang Medical College, Guiyang 550002, China
3Department of Pharmacy, Nanjing Medical University First Affiliated Hospital, Nanjing 210029, China

Received 24 January 2015; Revised 12 March 2015; Accepted 16 March 2015

Academic Editor: Zhuhua Zhang

Copyright © 2015 Donghui Zheng et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. Siegel, D. Naishadham, and A. Jemal, “Cancer statistics, 2013,” CA—Cancer Journal for Clinicians, vol. 63, no. 1, pp. 11–30, 2013. View at Publisher · View at Google Scholar · View at Scopus
  2. E. J. Woodward and C. Twelves, “Scheduling of taxanes: a review,” Current Clinical Pharmacology, vol. 5, no. 3, pp. 226–231, 2010. View at Publisher · View at Google Scholar · View at Scopus
  3. R. T. Dorr, “Pharmacology and toxicology of Cremophor EL diluent,” Annals of Pharmacotherapy, vol. 28, no. 5, supplement, pp. S11–S14, 1994. View at Google Scholar · View at Scopus
  4. J. Liebmann, J. A. Cook, and J. B. Mitchell, “Cremophor EL, solvent for paclitaxel, and toxicity,” The Lancet, vol. 342, no. 8884, p. 1428, 1993. View at Google Scholar · View at Scopus
  5. C. Tate, “Paclitaxel: infusion duration effect on toxicity and efficacy,” Cancer Control, vol. 2, no. 1, pp. 58–61, 1995. View at Google Scholar · View at Scopus
  6. M. L. Forrest, J. A. Yáñez, C. M. Remsberg, Y. Ohgami, G. S. Kwon, and N. M. Davies, “Paclitaxel prodrugs with sustained release and high solubility in poly(ethylene glycol)-b-poly(ε-caprolactone) micelle nanocarriers: pharmacokinetic disposition, tolerability, and cytotoxicity,” Pharmaceutical Research, vol. 25, no. 1, pp. 194–206, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. R. Yang, F. Meng, S. Ma, F. Huang, H. Liu, and Z. Zhong, “Galactose-decorated cross-linked biodegradable poly(ethylene glycol)-b-poly(ε-caprolactone) block copolymer micelles for enhanced hepatoma-targeting delivery of paclitaxel,” Biomacromolecules, vol. 12, no. 8, pp. 3047–3055, 2011. View at Publisher · View at Google Scholar · View at Scopus
  8. K. Letchford, R. Liggins, K. M. Wasan, and H. Burt, “In vitro human plasma distribution of nanoparticulate paclitaxel is dependent on the physicochemical properties of poly(ethylene glycol)-block-poly(caprolactone) nanoparticles,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 71, no. 2, pp. 196–206, 2009. View at Publisher · View at Google Scholar · View at Scopus
  9. C. Wang, Y. Wang, Y. Wang, M. Fan, F. Luo, and Z. Qian, “Characterization, pharmacokinetics and disposition of novel nanoscale preparations of paclitaxel,” International Journal of Pharmaceutics, vol. 414, no. 1-2, pp. 251–259, 2011. View at Publisher · View at Google Scholar · View at Scopus
  10. Y. Hu, J. Xie, Y. W. Tong, and C.-H. Wang, “Effect of PEG conformation and particle size on the cellular uptake efficiency of nanoparticles with the HepG2 cells,” Journal of Controlled Release, vol. 118, no. 1, pp. 7–17, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. T. Ishida, M. Ichihara, X. Wang et al., “Injection of PEGylated liposomes in rats elicits PEG-specific IgM, which is responsible for rapid elimination of a second dose of PEGylated liposomes,” Journal of Controlled Release, vol. 112, no. 1, pp. 15–25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. A. Leiva, F. H. Quina, E. Araneda, L. Gargallo, and D. Radić, “New three-arm amphiphilic and biodegradable block copolymers composed of poly(ε-caprolactone) and poly(N-vinyl-2-pyrrolidone). Synthesis, characterization and self-assembly in aqueous solution,” Journal of Colloid and Interface Science, vol. 310, no. 1, pp. 136–143, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. Y. Kaneda, Y. Tsutsumi, Y. Yoshioka et al., “The use of PVP as a polymeric carrier to improve the plasma half-life of drugs,” Biomaterials, vol. 25, no. 16, pp. 3259–3266, 2004. View at Publisher · View at Google Scholar · View at Scopus
  14. Z. Zhu, Y. Li, X. Li et al., “Paclitaxel-loaded poly(N-vinylpyrrolidone)-b-poly(ε-caprolactone) nanoparticles: preparation and antitumor activity in vivo,” Journal of Controlled Release, vol. 142, no. 3, pp. 438–446, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Le Garrec, S. Gori, L. Luo et al., “Poly(N-vinylpyrrolidone)-block-poly(d,l-lactide) as a new polymeric solubilizer for hydrophobic anticancer drugs: In vitro and in vivo evaluation,” Journal of Controlled Release, vol. 99, no. 1, pp. 83–101, 2004. View at Publisher · View at Google Scholar · View at Scopus
  16. H. Xu, Z. Hou, H. Zhang et al., “An efficient Trojan delivery of tetrandrine by poly(N-vinylpyrrolidone)-block-poly(epsilon-caprolactone) (PVP-b-PCL) nanoparticles shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion,” International Journal of Nanomedicine, vol. 9, no. 1, pp. 231–242, 2014. View at Publisher · View at Google Scholar · View at Scopus
  17. X. Li, X. Lu, H. Xu et al., “Paclitaxel/tetrandrine coloaded nanoparticles effectively promote the apoptosis of gastric cancer cells based on ‘oxidation therapy’,” Molecular Pharmaceutics, vol. 9, no. 2, pp. 222–229, 2012. View at Publisher · View at Google Scholar · View at Scopus
  18. R. Fatemeh, S. Naznin, A. Davood, and N. Farnaz, “Effects of chitosan concentration on the protein release behaviour of electrospun poly(ε-caprolactone)/chitosan nanofibers,” Journal of Nanomaterials. In press.
  19. D. Qu, G. Wang, Z. Wang et al., “5-Ethynyl-2′-deoxycytidine as a new agent for DNA labeling: detection of proliferating cells,” Analytical Biochemistry, vol. 417, no. 1, pp. 112–121, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. T. Zeng, H. Gao, P. Yu et al., “Up-regulation of kin17 is essential for proliferation of breast cancer,” PLoS ONE, vol. 6, no. 9, Article ID e25343, 2011. View at Publisher · View at Google Scholar · View at Scopus
  21. G. T. Williams and C. A. Smith, “Molecular regulation of apoptosis: genetic controls on cell death,” Cell, vol. 74, no. 5, pp. 777–779, 1993. View at Publisher · View at Google Scholar · View at Scopus
  22. J. M. Hardwick, Y.-B. Chen, and E. A. Jonas, “Multipolar functions of BCL-2 proteins link energetics to apoptosis,” Trends in Cell Biology, vol. 22, no. 6, pp. 318–328, 2012. View at Publisher · View at Google Scholar · View at Scopus
  23. J. M. Adams and S. Cory, “The Bcl-2 protein family: arbiters of cell survival,” Science, vol. 281, no. 5381, pp. 1322–1326, 1998. View at Publisher · View at Google Scholar · View at Scopus
  24. G. S. T. Smith, J. A. M. Voyer-Grant, and G. Harauz, “Monitoring cleaved caspase-3 activity and apoptosis of immortalized oligodendroglial cells using live-cell imaging and cleaveable fluorogenic-dye substrates following potassium-induced membrane depolarization,” Journal of Visualized Experiments, no. 59, Article ID e3422, 2012. View at Publisher · View at Google Scholar · View at Scopus
  25. B. Canbakan, H. Senturk, M. Canbakan, T. Toptas, and M. Tuncer, “Reliability of caspase activity as a biomarker of hepatic apoptosis in nonalcoholic fatty liver disease,” Biomarkers in Medicine, vol. 5, no. 6, pp. 813–815, 2011. View at Publisher · View at Google Scholar · View at Scopus
  26. M. Yin, Y. Yin, Y. Han, H. Dai, and S. Li, “Effects of uptake of hydroxyapatite nanoparticles into hepatoma cells on cell adhesion and proliferation,” Journal of Nanomaterials, vol. 2014, Article ID 731897, 7 pages, 2014. View at Publisher · View at Google Scholar · View at Scopus
  27. J. Mao, L. Wang, Z. Qian, and M. Tu, “Uptake and cytotoxicity of Ce(IV) doped TiO2 nanoparticles in human hepatocyte cell line L02,” Journal of Nanomaterials, vol. 2010, Article ID 910434, 8 pages, 2010. View at Publisher · View at Google Scholar · View at Scopus